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Abstract
Introduction: Hypocalcemia after thyroidectomy results in prolongation of hospitalization and patient discomfort but can be predicted 
by PTH assays. However, there is considerable variation in their use.
Methods: This study was undertaken to document current US and European practice patterns regarding the use of this assay. 
 Anonymous surveys were collected in 2009–2011 from members of the American Academies of Otolaryngology-Head and Neck 
 Surgery and Endocrine Surgery and the European, Italian, French, Spanish and British Societies of Endocrine Surgery.
Results: There were 356 American (3% response) and 61 European (10% response) respondents. 105 (29.8%) American and 25 (41%) 
European respondents reported routine PTH assay use. Fellowship trained surgeons reported increased use of the PTH assay (P = 0.004). 
Shorter reported average post-operative hospital stay was associated with American physicians (P = 0.0001), community practice loca-
tion (P = 0.0002) and routine calcium supplementation (P = 0.0015).
Conclusions: Surgical training was associated with routine use of the PTH assay. Average reported hospital stay was lower for 
 American and community practice physicians and correlated with post-operative oral calcium use.
Keywords: thyroidectomy, parathyroid hormone, standard of care, survey study, hypocalcemia, hypoparathyroidism
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Introduction
Hypocalcemia, a common complication after thyroi-
dectomy, results in prolongation of hospitalization 
and patient discomfort. It occurs transiently in up to 
30%, and permanently in up to 4% of patients after 
this procedure.1 Traditionally, predicting this com-
mon complication has been accomplished by follow-
ing calcium trends every 6–12 hours for 24–48 hours, 
after which levels generally plateau.2,3
Since 2002, numerous studies have shown that the 
parathyroid hormone (PTH) assay, checked minutes to 
hours after completing surgery, is excellent in predict-
ing those patients who will become  hypocalcemic.4–18 
Multiple algorithms detailing clinically-practical 
and cost-effective means to use PTH assay after thy-
roid surgery have been documented. A recent meta-
 analysis of studies published from 2002 through 2007 
addressed different methods.2 The authors concluded 
that obtaining a PTH level 1 to 6 hours following total 
or completion thyroidectomy has excellent accuracy 
in determining who will become hypocalcemic. 
While there have been many positive studies finding 
utility in post-operative PTH assays, a few reports 
have found PTH level is not able to accurately predict 
post-thyroidectomy hypocalcemia.19,20 Anecdotally, 
there appears to be considerable variation in practice 
regarding routine PTH assays among surgeons per-
forming this procedure.
In light of these practice variations, this survey 
study was undertaken to document current US and 
European practice patterns regarding the use of this 
assay, particularly in terms of how surgeon demo-
graphics are associated with use of the assay and 
whether use of the assay is related to reported length 
of hospitalization.
Materials and Methods
Approval for this study was obtained from the Insti-
tutional Review Board at Walter Reed Army Medi-
cal Center. The survey outlined in Table 1 was sent 
to 10,618 members of the American Academy of 
 Otolaryngology-Head and Neck Surgery  (AAO-HNS) 
and the American Association of Endocrine Surgeons 
(AAES). These surveys were distributed via email and 
paper copy to AAES and AAO-HNS surgeons twice 
from March 2009 thru November 2010. To ascertain 
the practice patterns of European physicians, the same 
survey (in English) was sent via online newsletter 
format to the 600 members of the European, Italian, 
French, Spanish and British Societies of Endocrine 
Surgery in 2010 and 2011.
No protected health information was collected. 
Settings were established electronically to exclude 
storage of IP addresses and any potential personal 
identifying information. Survey responses were orga-
nized in database format and analyzed using SAS 9.1, 
SAS Institute, Cary, NC. An alpha of 0.05 was used 
as the criterion for significance.
We began by examining the cutoffs used for all 
survey questions. N , 5 was selected as the cutoff 
for an insufficient number of responses. Individuals 
age 20–30, rate of permanent hypocalcemia . 6%, 
and rate of autotransplantation . 75% all had n = 4 
respondents and were collapsed into the closest 
 category. For basic analyses, chi-square tests were 
used unless predicted values dictated use of Fisher’s 
exact test. For the adjusted analyses, logistic regres-
sion was used with PTH assay usage, and rate of 
temporary/permanent hypocalcemia (ordered mul-
tinomial response model). Models were constructed 
with variables expected to be potential confounders 
without further refining. Discharge time was also 
modeled using ordered logistic regression. However, 
without a priori assumptions of expected contribu-
tors, automated backward selection was used with a 
staying criterion of an alpha of 0.10 to determine fac-
tors predictive of inpatient duration.
Results
Over 10,618 American resident and staff surgeons 
were surveyed. There were 356 respondents, cor-
responding to a response rate of 3.35%. Of the 
600 European physicians surveyed, 61 returned the 
survey, corresponding to a response rate of 10.1%. 
Among the American physicians, most respondents 
Table 1. Survey questions submitted via online and 
hardcopy.
Background information
What is your age?
What is your sex?
What type of training do you have (otolaryngology vs. 
general surgery, fellowship training)?
What type of practice (academic vs. private)?
how many years in practice?
how many thyroidectomies per year?
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Table 2. Survey respondents and training type.
characteristic category American european
Sex Male 87.9% 88.5%
Female 12.2% 11.5%
Age 20–40 19.2% 9.8%
40–50 38.3% 42.6%
.50 42.5% 47.5%
Years in  
independent  
practice
,2 8.8% 8.2%
2–10 26.8% 41.0%
10–20 33.1% 26.2%
.20 31.3% 24.6%
Number/year ,20 22.2% 9.8%
20–50 27.6% 8.2%
50–100 21.9% 11.5%
.100 28.4% 70.5%
Training type general  
(endocrine)  
surgery
35.7% 93.4%
Otolaryngology 64.3% 6.6%
Fellowship- 
trained
Yes 26.6% 44.3%
No 73.4% 55.7%
Practice type Academic 45.8% 93.4%
Community 54.2% 6.6%
had completed otolaryngology residency training 
programs without head and neck fellowship and 
were employed by either a group practice or aca-
demic institution. European physicians in the survey 
predominately represented general surgeons with 
a mixture of training levels and were based at aca-
demic institutions. American respondents reported 
a wide range of experience in thyroid surgery with 
22% reporting ,20 thyroidectomies/yr, 28% report-
ing 20–50/yr, 22% reporting 50–100/yr, and 28% 
reporting .100/yr. In contrast, 70% of European 
physicians reported .100 thyroidectomies per year, 
with the other frequencies each ∼10%. See Table 2 
for details.
Routine PTH assay use, whether alone or in 
conjunction with routine calcium monitoring, was 
reported by 105 (29.8%) American and 25 (41%) of 
European respondents. In the unadjusted analyses, 
assay use was correlated with sex (higher in men), 
years in practice (lower use in older physicians), fel-
lowship training (higher use in fellowship-trained) 
and an academic practice location (higher use in aca-
demic settings). The same relationships held true in 
the adjusted analysis, except for academic location, 
which was no longer significant after controlling for 
the other factors. See Table 3 for details.
Ta
bl
e 
3.
 C
or
re
la
tio
n 
be
tw
ee
n 
de
m
og
ra
ph
ic
/tr
ai
ni
ng
 p
at
te
rn
s 
an
d 
P
Th
 a
ss
ay
 u
se
 a
nd
 te
m
po
ra
ry
/p
er
m
an
en
t h
yp
oc
al
ce
m
ia
.
c
ha
ra
ct
er
is
tic
pT
H
 a
ss
ay
 u
se
Te
m
po
ra
ry
 h
yp
oc
al
ce
m
ia
pe
rm
an
en
t h
yp
oc
al
ce
m
ia
U
na
dj
us
te
d#
A
dj
us
te
d*
, ^
U
na
dj
us
te
d#
A
dj
us
te
d*
, ^
,$
U
na
dj
us
te
d#
A
dj
us
te
d*
, ^
S
ex
 (f
em
al
e)
P 
= 
0.
02
78
  
(lo
w
er
 in
 w
om
en
)
O
r
 =
 0
.2
93
  
(P
 =
 0
.0
05
7)
P
 =
 0
.0
98
7 
 
(lo
w
er
 in
 w
om
en
)
O
ve
ra
ll 
m
od
el
 is
  
no
t s
ig
ni
fic
an
t—
ie
,  
af
te
r a
dj
us
tin
g 
fo
r  
co
nf
ou
nd
in
g,
 th
es
e 
 
ch
ar
ac
te
ris
tic
s 
 
to
ge
th
er
 d
o 
no
t  
pr
ed
ic
t r
ep
or
te
d 
 
ra
te
 o
f t
em
po
ra
ry
  
hy
po
ca
lc
em
ia
P
 =
 0
.5
18
6 
 
(lo
w
er
 in
 w
om
en
)
O
r
 =
 0
.7
59
  
(P
 =
 0
.4
01
0)
Ye
ar
s 
in
 in
de
pe
nd
en
t  
pr
ac
tic
e
P 
= 
0.
00
06
  
(lo
w
er
 in
 m
or
e)
O
r
 =
 0
.6
40
  
(P
 =
 0
.0
00
4)
P
 =
 0
.7
56
9 
 
(in
cr
ea
se
d 
w
/#
 y
ea
rs
)
P
 =
 0
.3
83
8 
 
(in
cr
ea
se
d 
w
/#
 y
ea
rs
)
O
r
 =
 1
.3
42
  
(P
 =
 0
.0
13
6)
N
um
be
r o
f  
th
yr
oi
de
ct
om
ie
s/
ye
ar
P 
= 
0.
80
67
  
(in
cr
ea
se
 to
ge
th
er
)
O
r
 =
 0
.9
36
  
(P
 =
 0
.5
79
0)
P
 =
 0
.0
03
6 
 
(d
ec
re
as
e 
if 
# 
is
 h
ig
h)
P 
,
 0
.0
00
1 
 
(in
cr
ea
se
 to
ge
th
er
)
O
r
 =
 1
.2
50
  
(P
 =
 0
.0
45
1)
r
es
id
en
cy
  
(g
en
er
al
 s
ur
ge
ry
)
P 
= 
0.
07
48
  
(h
ig
he
r i
n 
ge
ne
ra
l s
ur
g)
O
r
 =
 1
.3
29
  
(P
 =
 0
.3
75
8)
P
 =
 0
.0
02
1 
 
(lo
w
er
 in
 g
en
er
al
 s
ur
g)
P
 =
 0
.0
01
9 
 
(h
ig
he
r i
n 
ge
ne
ra
l s
ur
g)
O
r
 =
 0
.6
99
  
(P
 =
 0
.2
35
3)
Fe
llo
w
sh
ip
 tr
ai
ni
ng
  
(y
es
)
P 
= 
0.
00
05
  
(h
ig
he
r i
f f
el
lo
w
sh
ip
)
O
r
 =
 1
.8
65
  
(P
 =
 0
.0
14
5)
P
 =
 0
.8
33
6 
 
(h
ig
he
r i
n 
fe
llo
w
sh
ip
)
P
 =
 0
.0
06
7 
 
(h
ig
he
r i
n 
fe
llo
w
sh
ip
)
O
r
 =
 1
.3
15
  
(P
 =
 0
.2
70
4)
P
ra
ct
ic
e 
ty
pe
  
(a
ca
de
m
ic
)
P 
= 
0.
00
45
  
(a
ca
de
m
ic
 h
ig
he
r)
O
r
 =
 1
.1
49
  
(P
 =
 0
.6
45
5)
P
 =
 0
.0
11
6 
 
(a
ca
de
m
ic
 lo
w
er
)
P 
,
 0
.0
00
1 
 
(a
ca
de
m
ic
 h
ig
he
r)
O
r
 =
 2
.5
89
  
(P
 =
 0
.0
01
0)
N
at
io
na
lit
y 
 
(A
m
er
ic
an
)
P 
= 
0.
08
33
  
(lo
w
er
 in
 A
m
er
ic
an
)
O
r
 =
 0
.8
61
  
(P
 =
 0
.6
52
7)
P
 =
 0
.0
19
7 
 
(h
ig
he
r i
n 
A
m
er
ic
an
)
P
 =
 0
.0
03
7 
(lo
w
er
 in
 
A
m
er
ic
an
)
O
r
 =
 0
.5
53
  
(P
 =
 0
.0
72
5)
n
ot
es
: #
C
hi
-s
qu
ar
e 
P
-v
al
ue
s;
 *l
og
is
tic
 re
gr
es
si
on
, a
dj
us
te
d 
fo
r s
ex
, y
ea
rs
 in
 p
ra
ct
ic
e,
 fe
llo
w
sh
ip
, n
at
io
na
lit
y,
 n
um
be
r/y
ea
r, 
pr
ac
tic
e 
ty
pe
, a
nd
 re
si
de
nc
y 
ty
pe
; ^
od
ds
 .
 1
 in
di
ca
te
 a
 h
ig
he
r c
ha
nc
e 
of
 re
po
rti
ng
 e
le
va
te
d 
ra
te
s 
of
 h
yp
oc
al
ce
m
ia
.
Stein et al
42 Clinical Medicine Insights: Endocrinology and Diabetes 2013:6
Table 6. Discharge timing.
Discharge time number reporting
Same day 17 (4.1%)
Next morning 187 (45.5%)
Next afternoon 58 (14.1%)
Two days 115 (28.0%)
Three days 34 (8.3%)
Table 4. reasons for assay non-use.
Use time number reporting
Intraoperatively 22 (15.9%)
In post-anesthesia care unit 49 (35.5%)
6 hours post-op 6 (4.4%)
Next morning 38 (27.5%)
Other 23 (16.7%)
Table 5. PTh assay usage timing.
Reasons number reporting
Lack of knowledge 21 (7.7%)
No change in management 92 (33.8%)
Not available 67 (24.6%)
Cost 47 (17.3%)
Not standard of care 33 (12.1%)
Other 12 (4.4%)
There was some variability in survey respondents 
regarding how they use the PTH assay. The most com-
mon usage was 1 hour following total thyroidectomy 
in the post-anesthesia care unit (35.5%), followed by 
the next day (27.5%). See Table 4 for details. There 
was no consensus among survey respondents regarding 
reasons for not using the PTH assay. Respondents cited 
lack of change in management (33.8%) and unavail-
ability of assay (24.6%) as the most common reasons 
for not utilizing the assay. See Table 5 for details.
The survey also queried self-reported estimates of 
the rates of temporary and permanent  hypocalcemia. 
In the unadjusted analysis, lower self-reported tempo-
rary hypocalcemia rate was associated with a higher 
number of thyroidectomies performed, general sur-
gery residency, academic practice and European phy-
sicians, but not sex, number of years in practice, or 
fellowship training. See Table 3 for details. In the 
adjusted logistic regression analysis, the available 
information did not significantly predict the rate of 
reported temporary hypocalcemia (overall P . 0.05), 
and therefore no individual characteristics were 
reported.
In both the adjusted and unadjusted analyses, a 
lower rate of self-reported permanent hypocalce-
mia rate was associated with number of thyroidec-
tomies performed annually, with an increase in rate 
as the number of surgeries per year increases (odds 
ratio = 1.256, P = 0.0451 adjusted), and with academic 
practice location (odds ratio = 2.589, P = 0.0010 
adjusted). Nationality, residency type and fellowship 
training were significant in the unadjusted analysis 
only, and years in independent practice became sig-
nificant only after adjustment. See Table 3 for details. 
Routine prophylactic use of calcium supplementation 
regardless of calcium status for post-thyroidectomy 
patients was split, with 42.5% of respondents using 
prophylactic calcium and 57.5% of responders not 
using prophylactic calcium.
Finally, the survey explored self-reported post-
operative hospitalizations. The most common time of 
discharge was the morning after surgery (see Table 6). 
Ordered logistic regression with backwards selection 
was used to evaluate for factors correlated with length 
of stay. Shorter average post-operative hospital stay for 
thyroidectomy patients was associated with American 
physicians (OR = 0.333, P = 0.0001) and the opinion 
that holding patients until calcium levels plateau is 
not necessary (OR = 0.218, P , 0.0001). Academic 
practice location (OR = 2.253, P = 0.0002) and lack 
of routine calcium supplementation (OR = 2.016, 
P = 0.0015) were associated with greater length of stay. 
Physicians who did not use the PTH assay reported 
shorter length of stay (OR = 0.630, P = 0.290). Years 
in independent practice, sex, residency type, fellow-
ship and number of thyroidectomies per year were 
not predictive (P . 0.10).
Discussion
It is well established that one of the most common 
complications of thyroid surgery is the development 
of hypocalcemia. The risk of hypoparathyroidism 
increases in reoperative thyroid surgery and when cen-
tral neck dissection is associated,21,22 decreases with 
the use of Harmonic scalpel.23 Traditionally, monitor-
ing and managing this complication is based on patient 
symptoms and serum calcium levels. Parathyroid hor-
mone is widely used in clinical practice in  diagnosing 
Use of parathyroid hormone assay after thyroidectomy
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primary and secondary hyperparathyroidism.24–26 
Within the last decade, the use of parathyroid hor-
mone assay has gained increasing use as a reliable 
tool to predict postoperative hypocalcemia within 
hours of total or complete thyroidectomy.1–14
It was determined through a polling of the audi-
ence during an instructional course given at the 2008 
American Academy of Otolaryngology—Head and 
Neck Surgery annual meeting that only about 4.5% 
of the surgeons in the audience used the PTH assay 
 postoperatively. Thus, it was surmised that the popu-
larity or knowledge of the PTH assay might be less than 
expected. A formal survey was created to elaborate 
on the questions posed to the audience at the annual 
meeting with the objective of exploring demographic 
factors related to assay use as well as determining any 
trends in post-thyroidectomy hospitalization.
Based on the results of our combined survey, we 
determined that a more accurate value of PTH assay 
utilization (alone or in combination with calcium 
trends) approximates 30% in the US and 40% in 
Europe. Furthermore, the provider responses indicate 
a significant relationship between type of surgical 
training and likelihood of utilizing the PTH assay. It 
was evident that individuals with fellowship train-
ing in head and neck surgery or endocrine surgery 
were more likely to use the PTH assay as part of their 
 routine post-thyroidectomy monitoring. The reason 
for this increased PTH assay utilization by fellowship-
trained individuals was not specifically explored with 
this survey. However, multiple potential explanations 
for this finding may be advanced. First, fellowship 
trained surgeons are more likely complete their train-
ing at larger tertiary care facilities where the assay is 
more readily available, thus they become accustomed 
to using the assay and ultimately make it part of their 
routine plan of care. Alternatively, these individuals 
may be more apt to practice at a tertiary care facil-
ity once completing their fellowship training, thus 
maintaining the availability of the assay for their use. 
Arguing against this second hypothesis is the finding 
that after adjusting for other factors (including fel-
lowship training), current practice location was not a 
significant predictor of PTH assay use.
Aside from these demographic trends and 
assay utilization, the questions posed in this sur-
vey were aimed at determining if any factors could 
be identified associated with post-thyroidectomy 
hospitalization protocols. It was determined that prac-
tice location, use of the PTH assay, nationality, and 
routine calcium supplementation are significantly asso-
ciated with self-reported post-operative  hospitalization. 
The relationship between the longer self-reported 
hospitalizations associated with PTH assay use is an 
unexpected  finding. Previous studies have explored 
the association of shorter hospitalization and cost sav-
ings with the use of the PTH assay. In particular, Payne 
et al described a protocol in which 1 and 6- hour post-
 thyroidectomy monitoring of PTH and  corrected cal-
cium have led to fewer blood tests, a 10-hour reduction 
in length of hospital stay and ultimately a cost sav-
ings of $766 per patient.27 A similar study published 
by Cote et al explored using the PTH assay alone as 
a means for cost savings at their institution.17 They 
determined that a 1-hour PTH cutoff of ,15 ng/L 
should serve as an indication for prophylactic calcium 
supplementation. Per their report, this resulted in an 
approximate 20% reduction in hospitalization duration 
that resulted in cost savings for their institution. Given 
this background, we speculate that our findings of lon-
ger hospitalization are more appropriately interpreted 
in the reverse—physicians with longer length of stay 
(LOS) are starting to turn to the assay in an attempt to 
better identify patients who can be discharged safely 
at an earlier time point. Other factors not explored in 
this survey, such as complexity of surgery performed, 
particularly in benign vs. neoplastic disease, may also 
account for some of this difference.
When interpreting the results of this survey, 
we acknowledge the inherent weaknesses of this 
investigation. The study design itself opens itself to 
bias, as all data is self-reported. We did not prevent 
repeated completion of the survey by each respon-
dent; however we doubt that many surgeons would 
be likely to complete the survey more than once. 
The response rate of 3.35% among the American 
physicians was low, and the European physicians 
were polled within a limited group, which restricts 
our ability to generalize our findings. These low 
response rates are probably results of time con-
straints experienced by most surgeons as well as the 
large number of survey studies that are received by 
most physicians.
Additionally, our attempts to measure some poten-
tial confounding factors probably omitted some 
contributing factors. Unmeasured confounders may 
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account for some of the relationships or lack thereof 
seen in this data.
Despite the low response rate, the results of this 
surgeon survey provides valuable information sug-
gesting interesting relationships between training 
type and propensity for PTH assay utilization, as 
well as post-operative hospitalization patterns related 
not only to training type but to PTH assay utilization 
and post-operative calcium supplementation. These 
results set the stage for considering further studies 
aimed at considering if and how demographic and 
training factors, specifically training type as identi-
fied in this survey study, impact the use of the assay 
and ultimately change standards of care. This survey 
also illuminates the large degree of practice variation 
in this area, suggesting either that best practices have 
not yet been determined, or inefficiency in their adop-
tion among surgeons performing this procedure.
conclusions
Approximately one-third of thyroid surgeons sur-
veyed routinely obtain PTH assays for patients 
undergoing thyroidectomy, and the use of the assay 
is associated with sex, fellowship completion, and 
years in  practice. Further studies about use patterns 
and adoption of best practices appear warranted.
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